Patent · US Expired

4-methyl-5-(2-(4-phenylpiperazin-1-yl)ethyl)thiazole derivatives their method of preparation and the pharmaceutical compositions in which they are present

US5120736A · kind A · utility

3Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 1991
Grant dateJun 9, 1992
Priority date
Expiry dateApr 11, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel 4-methyl-5-[2-(4-phenylpiperazin-1-yl)ethyl]thiazole derivatives of the general formula ##STR1## in which R is selected from a hydrogen atom, an alkyl radical having from 2 to 7 carbon atoms and an aralkyl radical of which the aryl moiety preferably consists of phenyl and of which the alkyl moiety has from 1 to 4 carbon atoms, and to the pharmaceutically acceptable salts of these derivatives. It further relates to a method of preparing these products and to pharmaceutical compositions in which they are incorporated. These derivatives are applied especially in the preparation of drugs intended for the treatment of functional dysuria associated with hyperactivity of the .alpha.-adrenergic sympathetic nervous system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.